Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V
Aphex BioCleanse Systems Inc Files for Bankruptcy Protection under Chapter 11, Subchapter V
Venice, FL, May 19, 2022 (GLOBE NEWSWIRE) -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST), has filed a voluntary petition under the Federal Bankruptcy Code, Chapter 11, Subchapter V. The Petition was filed on May 12, 2022 in the United States Bankruptcy Court Middle District of Florida Tampa Division.
威尼斯，佛罗里达州，2022年5月19日(Global Newswire)--Aphex BioCleanse Systems，Inc.(OTCPK：SNST)已根据联邦破产法第11章第五小节提交了一份自愿请愿书。请愿书于2022年5月12日在佛罗里达州坦帕市中区美国破产法院提交。
The filing was precipitated by the litigatory actions of certain former Directors and Officers that while unfounded have damaged the business integrity of the Company and endangered the Company's shareholders as well as inhibiting the ability of the Company to raise working capital and market its products.
该申请是由某些前董事和高级管理人员的诉讼行为引发的，这些诉讼行为虽然没有根据，但损害了公司的商业诚信，危及公司股东，并抑制了公司筹集营运资金和营销其产品的能力。
The actions of these persons have included illegal and unfounded filings in Nevada, and numerous erroneous and illegal emails and communications designed to misinform Company Shareholders and Distributors. This includes the Former CEO and Chairman executing false documents impersonating the CEO and other Officer Titles of the Company MONTHS after being terminated for cause. This former CEO is now instrumental in leading the attempts to damage and take over the company.
这些人的行为包括在内华达州非法和毫无根据的文件，以及许多错误和非法的电子邮件和通讯，旨在误导公司股东和分销商。这包括前首席执行官和董事长在被因故解雇几个月后假冒公司首席执行官和其他高级管理人员头衔执行虚假文件。这位前首席执行官现在在领导破坏和接管公司的努力中发挥了重要作用。
Aphex plans to submit a timely reorganization plan and seek Debtor in Possession Financing to drive the marketing of its unique sanitizing water known as Hy-IQ and related products.
Aphex计划及时提交重组计划，并寻求债务人占有融资，以推动其独特的消毒水Hy-IQ和相关产品的营销。
About Aphex BioCleanse Systems, Inc. (Aphex):
关于Aphex BioCleanse Systems公司(Aphex)：
Aphex is the developer of the world's first proprietary non-alcohol, non-toxic, hydrogen-based cleaning technology, and has been producing germ killing solutions for over 10 years. The technology, called Hy-IQ® Water, has a unique method of sanitizing that you won't find anywhere else. Hy-IQ® Water uses hydrogen ions traveling nearly at the speed of light to breach the cell walls of exoskeleton germs.
Aphex是世界上第一个专有的无酒精、无毒、基于氢气的清洁技术的开发商，10多年来一直在生产杀菌解决方案。这项名为Hy-IQ的技术®水，有一种独特的消毒方法，你在其他地方找不到的。HY-IQ®水利用氢离子以接近光速的速度穿透外骨骼细菌的细胞壁。
"We Kill Germs with Physics, Not Chemistry" is a tagline that expresses their commitment to the environment by providing non-Chemical solutions to the spread of dangerous pathogens. Killing the most dangerous germs on the planet, while meeting the EPA's definition of "Water", is revolutionary.
“我们用物理而不是化学杀死细菌”是一句标语，通过为危险病原体的传播提供非化学解决方案来表达他们对环境的承诺。消灭地球上最危险的细菌，同时满足环境保护局对“水”的定义，是一种革命性的做法。
To find out more about Aphex and their technologies, visit Aphex BioCleanse Systems, Inc. - Superior Sanitization (aphexus.com)
欲了解更多有关Aphex及其技术的信息，请访问Aphex BioCleanse Systems，Inc.-Superior Sanitiization(apexus.com)。
Forward Looking Statements:
前瞻性陈述：
This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future, including but not limited to, any products sold or cash flow from operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
本新闻稿包含“前瞻性陈述”，这一术语在1933年的美国证券法第27A节和1934年的证券交易法第21E节中有定义。本新闻稿中非纯粹历史性的陈述为前瞻性陈述，包括有关对未来的信念、计划、预期或意图的任何陈述，包括但不限于已售出的任何产品或来自运营的现金流。由于许多因素，实际结果可能与任何前瞻性陈述中预测的结果不同。这些因素除其他外，包括与分销有关的内在不确定性，以及与以可接受的条件获得融资有关的困难。这些前瞻性陈述是截至本新闻稿发布之日作出的，我们没有义务更新前瞻性陈述，也没有义务更新实际结果可能与前瞻性陈述中预测的结果不同的原因。尽管我们相信本新闻稿中包含的信念、计划、预期和意图是合理的，但不能保证这些信念、计划、预期或意图将被证明是准确的。投资者应参考本文中列出的所有信息，也应参考我们上一财年的最新年度报告、我们的季度报告以及不定期向美国证券交易委员会提交的其他定期报告。
Investor Contact:
投资者联系方式：
Anthony Marrotti
585-880-1567
安东尼·马罗蒂
585-880-1567
译文内容由第三方软件翻译。